Stockscreener 앱 받기
0.12%
Pfizer Inc 주식(PFE)의 최신 뉴스
AI Transforms Pharmaceutical Packaging as Industry Invests Billions in Zero-Defect Quality Control Systems - GlobeNewswire Inc.
BMO Capital Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $34 - Moomoo
Moderna Stock Is Up 6% Today: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax? - 24/7 Wall St.
Pfizer vs Eli Lilly: Different Bets on Pharma M&A - Yahoo Finance
Is Most-Watched Stock Pfizer Inc. (PFE) Worth Betting on Now? - Yahoo Finance Singapore
Pfizer (PFE) Stock; Edges Lower as Investors Weigh Ongoing COVID Franchise Pressure - CoinCentral
Pfizer Stock Faces a Fresh COVID Patent Overhang as Investors Wait for Its Next Growth Act - TechStock²
Pfizer Advances Oncology Portfolio While Extending Vyndamax Cash Flow Visibility - Yahoo Finance
Pfizer (PFE) Surpasses Q1 Earnings Expectations, Reaffirms 2026 Sales Guidance - GuruFocus
Pfizer Viagra stock: what investors and health-conscious readers need to know in 2026 - Portal CNJ
What Pfizer (PFE)'s Earnings Beat, Reaffirmed Guidance and Oncology Wins Mean For Shareholders - simplywall.st
Great Hill Capital LLC's Pfizer Inc(PFE) Holding History - GuruFocus
GSA CAPITAL PARTNERS LLP's Pfizer Inc(PFE) Holding History - GuruFocus
Pfizer (PFE) Beats EPS Estimates, Reaffirms Full-Year Outlook - GuruFocus
Pfizer Inc. stock (US7170811035): Q1 2026 results and recent share price move - AD HOC NEWS
Opportunities to Drive Change in Alopecia Areata - Pfizer
Here is Why Pfizer (PFE) One of the Best High Volume Stocks to Invest In - Insider Monkey
Pfizer Inc (PFE) Shares Fall 3.0% -- What GF Score of 76 Tells I - GuruFocus
Pfizer Options Spot-On: On May 8th, 207.87K Contracts Were Traded, With 2.63 Million Open Interest - Moomoo
-3.15% for Pfizer stock as new share registration weighs on outlook - Traders Union
Novavax Inc stock (US66987V1098): Shares jump on Q1 beat and Pfizer deal momentum - AD HOC NEWS
Earnings recap: Airbnb, AMD, Shopify, Pfizer, Uber, Arm, Disney… - Proactive financial news
Novavax (NVAX) Soars After Earnings Beat And Pfizer Deal - StocksToTrade
Novavax Stock Jumps As Pfizer Deal Cash Puts Vaccine Turnaround Back In Focus - TechStock²
Pfizer Terminates Early-Stage Cancer Trial: What It Means for PFE Investors - TipRanks
Duavee by Pfizer, Inc - Pharmacy Times
Novavax Stock Jumps As Pfizer Deal And Q1 Beat Energize Traders - timothysykes.com
Assessing Pfizer’s (PFE) Valuation As Shares Hover Near Recent Levels - simplywall.st
Small Molecule Drug Discovery Market Is Going to Boom Rapidly | Pfizer Inc., Merck & Co., Inc., Novartis AG - openPR.com
PFE.DE Technical Analysis | Trend, Signals & Chart Patterns | PFIZER INC (FRA:PFE) - ChartMill
Is Pfizer’s 6.5% Dividend a Yield Trap? Q1 Results Put Speculation to Rest - NAI500
Judge Knocks Out Pfizer Partner's Vax Case Against GSK - Law360
Pfizer Options Spot-On: On May 7th, 299.38K Contracts Were Traded, With 2.62 Million Open Interest - Moomoo
Pfizer Ends Early-Stage Lymphoma Combo Trial, Trimming a Small Piece of Its Oncology Upside - TipRanks
Pfizer’s Next Lyme Shot: What a Fifth-Dose VLA15 Trial Signals for PFE Investors - TipRanks
Novavax, Inc. Stock Jumps: Why Pfizer’s Matrix-M Deal Drove a Surprise Q1 Revenue Beat - TechStock²
Inside the Pfizer CentreOne OSD Network - Contract Pharma
Analysts Conflicted on These Healthcare Names: Pfizer (PFE), Spyre Therapeutics (SYRE) and Adaptive Biotechnologies (ADPT) - The Globe and Mail
Is Pfizer Stock Worth Buying After a Q1 2026 Beat and Patent Win? - TIKR.com
Pfizer Works to Address Inequities in IBD Care - Pfizer
Pfizer's 6.5% Dividend Yield Looked Too Good to Be True -- but Management Just Silenced the Skeptics - Yahoo Finance
How Pfizer’s Q1 Beat, Oncology Wins and Patent Deals At Pfizer (PFE) Has Changed Its Investment Story - Yahoo Finance
Is It Time To Reconsider Pfizer (PFE) After Recent Share Price Rebound? - simplywall.st
Pfizer and Our CEO Albert Bourla Recognized by TIME, Fortune - Pfizer
CEO Albert Bourla Reflects on Pfizer’s Year of Bold Moves and Relentless Innovation in 2025 Annual Review - Pfizer
Pfizer To Go Ex-Dividend On May 8th, 2026 With 0.43 USD Dividend Per Share - Moomoo
AI in Healthcare? Pfizer, Anthropic, and Longevity Scientists Think It’s Critical - Yahoo Finance
Pfizer Earnings Call Highlights Growth Beyond COVID - The Globe and Mail
Interviews: How To Upskill In A Lockdown - Pfizer
Tunica-Biloxi Tribe receives grant from Pfizer to expand healthcare in Central Louisiana - WGNO
Novavax (NVAX) Finds a New Revenue Engine in Pfizer Licensing - AlphaStreet
Pfizer’s newer medicines carry more weight in Q1 - thestreet.com
Pfizer's COVID-19 Oral Antiviral Treatment Transitioning from Government Distribution - Pfizer
Meet The People Of PGS: Craig - Pfizer
Understanding Your Thyroid: The Key to Energy & Health - Pfizer
PFIZER INC : DZ Bank reiterates its Buy rating - marketscreener.com
Pfizer Stock Gains Ground Following Better Than Expected Q1 Financial Results - TIKR.com
Pfizer Q1 Earnings Beat: Should You Finally Buy PFE as Pharma Play? - Gotrade
A Look At Pfizer (NYSE:PFE) Valuation After Q1 2026 Beat And Pipeline Progress - Yahoo Finance
PFIZER INC : UBS remains Neutral - marketscreener.com
Can Pfizer Stock Outrun A $17B Revenue Void? - Yahoo Finance
Novavax stock rises after Q1 2026 beat (NVAX:NASDAQ) - Seeking Alpha
Pfizer Inc. (NYSE:PFE) Q1 2026 Earnings Call Transcript - Insider Monkey
PFIZER INC : Jefferies reaffirms its Buy rating - marketscreener.com
Analysts Offer Insights on Healthcare Companies: GeneDx Holdings (WGS), Pfizer (PFE) and Travere Therapeutics (TVTX) - The Globe and Mail
FDA Appoints Szarama to CBER; Pfizer and Lilly Report Earnings - geneonline.com
Pfizer Awarded Diamond Resiliency Badge for Supply Chain Excellence - Pfizer
2.04%
0.43%
자본화:
|
볼륨(24시간):